Barclays lowered the firm’s price target on Clarivate (CLVT) to $4 from $5 and keeps an Underweight rating on the shares. The company reported “poor” Q4 results, pulled guidance, “questionable” buybacks, and a “Value Creation Plan” that does not appear large enough in scope to make a material difference, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
Questions or Comments about the article? Write to editor@tipranks.com